Adelaide Research & Scholarship: Search

Search

Results 1-9 of 9 (Search time: 0.002 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2006	TWEAK is a novel arthritogenic mediator	Perper, S.; Browning, B.; Burkly, L.; Weng, S.; Gao, C.; Giza, K.; Su, L.; Tarilonte, L.; Crowell, T.; Rajman, L.; Runkel, L.; Scott, M.; Atkins, G.; Findlay, D.; Zheng, T.; Hess, H.
	2002	Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism	Findlay, D.; Raggatt, L.; Bouralexis, S.; Hay, S.; Atkins, G.; Evdokiou, A.
	1999	Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells is Accompanied by Induction of p21 WAF1/CIP1 and G2/M Arrest	Evdokiou, A.; Raggatt, L.; Findlay, D.; Atkins, G.
	2011	Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo	Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.; Zannettino, A.; Evdokiou, A.
	2002	Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis	Atkins, G.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Labrinidis, A.; Zannettino, A.; Haynes, D.; Findlay, D.
	2003	Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis	Evdokiou, A.; Labrinidis, A.; Bouralexis, S.; Hay, S.; Findlay, D.
	2009	Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer	Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A.
	2009	Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model	Labrinidis, A.; Hay, S.; Liapis, V.; Ponomarev, V.; Findlay, D.; Evdokiou, A.
	2011	Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway	Wijenayaka, A.; Kogawa, M.; Lim, H.; Bonewald, L.; Findlay, D.; Atkins, G.; Carvalho, D.P.D.